风险分析指数在门诊患者中评估衰弱的验证研究
本研究在门诊患者中验证风险分析指数(RAI)评估衰弱的效果。研究纳入28059例门诊患者,测量RAI中位时间仅30秒。衰弱患者1年死亡率为正常者的2至5倍,例如未接受小手术的衰弱患者风险比为3.69(95%CI 2.51-5.41),对应30、180、365天死亡率分别为2.9%、11.2%、17.4%,而正常者分别为0.3%、2.3%、4.0%。判别能力优秀,c值范围0.838至0.909。
要点
- RAI可在门诊快速评估衰弱,中位测量时间仅30秒。
- 衰弱患者1年死亡率为正常者的2至5倍。
- RAI对死亡判别能力优秀,c值0.838至0.909。
核心结论
- RAI是门诊人群中有效且易于实施的即时衰弱评估工具,可帮助医患做出更知情的照护决策,尤其适用于高风险且预期寿命有限的患者。
主要发现
- 在28059例患者中,13861例匹配到小规模办公室操作,14198例未接受任何操作;平均(标准差)年龄为56.7(17.2)岁,女性占15797例(56.3%)。
- 测量RAI的中位时间(四分位距第25至75百分位)为30(22-47)秒。
- 衰弱患者的死亡率是RAI评分正常患者的2至5倍;例如未接受小规模操作的衰弱门诊患者风险比为3.69(95%CI 2.51-5.41),对应30、180、365天死亡率分别为2.9%、11.2%、17.4%,而正常RAI评分患者分别为0.3%、2.3%、4.0%。
- 死亡判别能力优秀,总体及截尾于30、180、365天时c值范围从接受小规模操作后30天死亡的0.838(95%CI 0.773-0.902)到未接受操作的0.909(95%CI 0.855-0.964)。
临床怎么用
- 在门诊环境中可使用RAI快速识别衰弱患者,测量仅需约30秒,有助于对高风险患者进行照护决策和预后沟通。
局限性
- 研究仅在同一医疗系统的门诊手术诊所进行,外部推广性需进一步验证;原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frailty is a marker of dependency, disability, hospitalization, and mortality in community-dwelling older adults. However, existing tools for measuring frailty are too cumbersome for rapid point-of-care assessment. The Risk Analysis Index (RAI) of frailty is validated in surgical populations, but its performance outside surgical populations is unknown. OBJECTIVE: Validate the RAI in ambulatory patients. DESIGN, SETTING, AND PARTICIPANTS: Observational cohort study of outpatient surgical clinics within the University of Pittsburgh Medical Center Healthcare System between July 1, 2016, and December 31, 2016. Frailty was assessed using the RAI. Current Procedural Terminology codes following RAI assessment identified patients with and without minor office-based procedures (eg, joint injection, laryngoscopy). MAIN OUTCOMES AND MEASURES: All-cause 1-year mortality, assessed by stratified Cox proportional hazard models. RESULTS: Of 28,059 patients, 13,861 were matched to a minor, office-based procedure and 14,198 did not undergo any procedure. The mean (SD) age was 56.7 (17.2) years; women constituted 15,797 (56.3%) of the cohort. Median time (interquartile range 25th-75th percentile) to measure RAI was 30 (22-47) seconds. Mortality among the frail was two to five times that of patients with normal RAI scores. For example, the hazard ratio for frail ambulatory patients without a minor procedure was 3.69 (95% confidence interval [CI] = 2.51-5.41), corresponding to 30-, 180-, and 365-day mortality rates of 2.9%, 11.2%, and 17.4%, respectively, compared to 0.3%, 2.3%, and 4.0% among patients with normal RAI scores. Discrimination of mortality (overall, and censored at 30, 180, and 365 days) was excellent, ranging from c = 0.838 (95% CI = 0.773-0.902) for 30-day mortality after minor procedures to c = 0.909 (95% CI = 0.855-0.964) without a procedure. CONCLUSION: RAI is a valid, easily administered tool for point-of-care frailty assessment in ambulatory populations that may help clinicians and patients make better informed decisions about care choices-especially among patients considered high risk with a potentially limited life span. J Am Geriatr Soc 68:1818-1824, 2020.
引用
- Shah R, Borrebach JD, Hodges JC, et al. Validation of the Risk Analysis Index for Evaluating Frailty in Ambulatory Patients. J Am Geriatr Soc. 2020. PMID: 32310317. doi:10.1111/jgs.16453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。